Patents by Inventor Marit RODE

Marit RODE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250057946
    Abstract: Disclosed are salmon interferon sequences useful as adjuvants in fish vaccines. Also disclosed are fish vaccines utilizing said interferon sequences and methods for prevention of fish infections utilizing these vaccines.
    Type: Application
    Filed: December 19, 2022
    Publication date: February 20, 2025
    Inventors: Oyvind Haugland, Marius Andre de Feijter Karlsen, Linda Helena Hauge, Marit Rode
  • Publication number: 20250057937
    Abstract: Disclosed is a system for targeting expression of antigens delivered via DNA vaccines to cell surface. Antigens, vaccines, and methods of using of these vaccines in prevention of fish from infections are also disclosed.
    Type: Application
    Filed: December 19, 2022
    Publication date: February 20, 2025
    Inventors: Oyvind Haugland, Marius Andre de Feijter Karlsen, Linda Helena Hauge, Marit Rode
  • Patent number: 10703781
    Abstract: The present invention relates to a piscine myocarditis virus (PMCV) virus-like particle (VLP) which consists only of PMCV ORF1 protein.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: July 7, 2020
    Assignee: PHARMAQ AS
    Inventors: Pal Nilsen, Marit Rode
  • Publication number: 20200002385
    Abstract: The present invention relates to a piscine myocarditis virus (PMCV) virus-like particle (VLP) which consists only of PMCV ORF1 protein.
    Type: Application
    Filed: August 19, 2019
    Publication date: January 2, 2020
    Inventors: Pal NILSEN, Marit RODE
  • Patent number: 10428117
    Abstract: The present invention relates to a piscine myocarditis virus (PMCV) virus-like particle (VLP) which consists only of PMCV ORF1 protein.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: October 1, 2019
    Assignee: PHARMAQ AS
    Inventors: Pal Nilsen, Marit Rode
  • Publication number: 20180215793
    Abstract: The present invention relates to a piscine myocarditis virus (PMCV) virus-like particle (VLP) which consists only of PMCV ORF1 protein.
    Type: Application
    Filed: January 30, 2018
    Publication date: August 2, 2018
    Inventors: Pal NILSEN, Marit RODE